{"settings":{"languages":["en"],"forceNER":true,"tag":"nlp","threshold":0.5,"autoLoad":true,"autoSave":true,"modelFileName":"model.nlp","executeActionsBeforeAnswers":false,"calculateSentiment":true},"nluManager":{"settings":{"tag":"nlu-manager"},"locales":["en"],"languageNames":{},"domainManagers":{"en":{"settings":{"locale":"en","trainByDomain":false,"tag":"domain-manager-en","nluByDomain":{"default":{"className":"NeuralNlu","settings":{}}},"useStemDict":true},"stemDict":{"a,car-t,is,therapi,tisagenlecleucel":{"intent":"drug_identification","domain":"default"},"acut,leukemia,lymphoblast,treatment":{"intent":"disease_identification","domain":"default"},"approv,breakthrough,fda,for,therapi":{"intent":"regulatory_identification","domain":"default"},"clinic,ii,phase,result,trial":{"intent":"clinical_trial","domain":"default"}},"intentDict":{"drug_identification":"default","disease_identification":"default","regulatory_identification":"default","clinical_trial":"default"},"sentences":[{"domain":"default","utterance":"Tisagenlecleucel is a CAR-T therapy","intent":"drug_identification"},{"domain":"default","utterance":"Acute lymphoblastic leukemia treatment","intent":"disease_identification"},{"domain":"default","utterance":"FDA approval for breakthrough therapy","intent":"regulatory_identification"},{"domain":"default","utterance":"Phase II clinical trial results","intent":"clinical_trial"}],"domains":{"master_domain":{"settings":{"locale":"en","tag":"nlu-en","keepStopwords":true,"nonefeatureValue":1,"nonedeltaMultiplier":1.2,"spellCheck":false,"spellCheckDistance":1,"filterZeros":true,"log":true},"features":{"tisagenlecleucel":1,"is":1,"a":1,"car-t":1,"therapi":1,"acut":1,"lymphoblast":1,"leukemia":1,"treatment":1,"fda":1,"approv":1,"for":1,"breakthrough":1,"phase":1,"ii":1,"clinic":1,"trial":1,"result":1},"intents":{"drug_identification":1,"disease_identification":1,"regulatory_identification":1,"clinical_trial":1},"intentFeatures":{"drug_identification":{"tisagenlecleucel":1,"is":1,"a":1,"car-t":1,"therapi":1},"disease_identification":{"acut":1,"lymphoblast":1,"leukemia":1,"treatment":1},"regulatory_identification":{"fda":1,"approv":1,"for":1,"breakthrough":1,"therapi":1},"clinical_trial":{"phase":1,"ii":1,"clinic":1,"trial":1,"result":1}},"featuresToIntent":{"tisagenlecleucel":["drug_identification"],"is":["drug_identification"],"a":["drug_identification"],"car-t":["drug_identification"],"therapi":["drug_identification","regulatory_identification"],"acut":["disease_identification"],"lymphoblast":["disease_identification"],"leukemia":["disease_identification"],"treatment":["disease_identification"],"fda":["regulatory_identification"],"approv":["regulatory_identification"],"for":["regulatory_identification"],"breakthrough":["regulatory_identification"],"phase":["clinical_trial"],"ii":["clinical_trial"],"clinic":["clinical_trial"],"trial":["clinical_trial"],"result":["clinical_trial"]},"neuralNetwork":{"settings":{"locale":"en","tag":"nlu-en","keepStopwords":true,"nonefeatureValue":1,"nonedeltaMultiplier":1.2,"spellCheck":false,"spellCheckDistance":1,"filterZeros":true,"log":true},"features":["tisagenlecleucel","is","a","car-t","therapi","acut","lymphoblast","leukemia","treatment","fda","approv","for","breakthrough","phase","ii","clinic","trial","result"],"intents":["drug_identification","disease_identification","regulatory_identification","clinical_trial"],"perceptrons":[[2.94834303855896,2.94834303855896,2.94834303855896,2.94834303855896,2.1552846431732178,-0.2360951453447342,-0.2360951453447342,-0.2360951453447342,-0.2360951453447342,-0.7769610285758972,-0.7769610285758972,-0.7769610285758972,-0.7769610285758972,-0.17646381258964539,-0.17646381258964539,-0.17646381258964539,-0.17646381258964539,-0.17646381258964539,0.8317621162386295],[-0.2154441922903061,-0.2154441922903061,-0.2154441922903061,-0.2154441922903061,-0.47971582412719727,3.3971447944641113,3.3971447944641113,3.3971447944641113,3.3971447944641113,-0.23609139025211334,-0.23609139025211334,-0.23609139025211334,-0.23609139025211334,-0.28125908970832825,-0.28125908970832825,-0.28125908970832825,-0.28125908970832825,-0.28125908970832825,1.3192438536166091],[-0.77729731798172,-0.77729731798172,-0.77729731798172,-0.77729731798172,2.155139446258545,-0.21535785496234894,-0.21535785496234894,-0.21535785496234894,-0.21535785496234894,2.948479413986206,2.948479413986206,2.948479413986206,2.948479413986206,-0.19741502404212952,-0.19741502404212952,-0.19741502404212952,-0.19741502404212952,-0.19741502404212952,0.8303820110663035],[-0.19731773436069489,-0.19731773436069489,-0.19731773436069489,-0.19731773436069489,-0.4077293872833252,-0.2807362973690033,-0.2807362973690033,-0.2807362973690033,-0.2807362973690033,-0.17640389502048492,-0.17640389502048492,-0.17640389502048492,-0.17640389502048492,2.8120102882385254,2.8120102882385254,2.8120102882385254,2.8120102882385254,2.8120102882385254,1.0256963836169173]]}}}}},"intentDomains":{},"extraSentences":[["en","Tisagenlecleucel is a CAR-T therapy"],["en","Acute lymphoblastic leukemia treatment"],["en","FDA approval for breakthrough therapy"],["en","Phase II clinical trial results"]]},"ner":{"settings":{"tag":"ner","entityPreffix":"%","entitySuffix":"%"},"rules":{"en":{"drug":{"name":"drug","type":"enum","rules":[{"option":"Tisagenlecleucel","texts":["Tisagenlecleucel"]}]},"therapy_type":{"name":"therapy_type","type":"enum","rules":[{"option":"CAR-T therapy","texts":["CAR-T therapy"]}]},"disease":{"name":"disease","type":"enum","rules":[{"option":"Acute lymphoblastic leukemia","texts":["Acute lymphoblastic leukemia"]}]},"regulatory_body":{"name":"regulatory_body","type":"enum","rules":[{"option":"FDA","texts":["FDA"]}]},"approval_type":{"name":"approval_type","type":"enum","rules":[{"option":"breakthrough therapy","texts":["breakthrough therapy"]}]},"trial_phase":{"name":"trial_phase","type":"enum","rules":[{"option":"Phase II","texts":["Phase II"]}]},"study_type":{"name":"study_type","type":"enum","rules":[{"option":"clinical trial","texts":["clinical trial"]}]}}}},"nlgManager":{"settings":{"tag":"nlg-manager"},"responses":{}},"actionManager":{"settings":{"tag":"action-manager"},"actions":{}},"slotManager":{}}